Bioavailability of curcumin: problems and promises.
By P. Anand, A. Kunnumakkara, R. Newman, Bharat B. Aggarwal. Molecular Pharmaceutics, 2007
5,311 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/01d71ae294672b7102b0bd4455af5d6fb677788b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Molecular Medicine
- Bharat B. Aggarwal
- S. Prasad
- Bokyung Sung
- A. Kunnumakkara
- P. Anand
- K. Harikumar
- Raghavendhar R. Kotha
- Devanand L. Luthria
In Pharmacology
- Bharat B. Aggarwal
- P. Anand
- Bokyung Sung
- Raghavendhar R. Kotha
- Devanand L. Luthria
- A. Kunnumakkara
- S. Prasad
- D. Kalman
Citations in the corpus
- Curcumin: A Review of Its’ Effects on Human Health (2017, background): “major problems with ingesting curcumin by itself is its poor bioavailability [15], which appears to be primarily due to poor absorption, rapid metabolism, and rapid elimination.”
- α-Terpineol, a natural monoterpene: A review of its biological properties (2018, background): “Because of the insufficient aqueous solubility and bioavailability of curcumin, it is not widely used in the clinical field for treatment of cancer and other diseases [74].”
- Carotenoids: biochemistry, pharmacology and treatment (2016, background): “Despite the lower bioavailability of curcumin, its therapeutic efficiency has been proven in different human diseases including CVDs, diabetes, cancer, arthritis, Crohn’s disease and neurological diseases (Anand et al., 2007; Gupta et al., 2013).”
- Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. (2014, background): “the parent compound, such as liposomal, nanoparticulated, and phospholipid complex formulations of curcumin [250].”
- Novel insights of dietary polyphenols and obesity. (2014, background): “After eating polyphenol-rich foods or taking dietary supplement, humans achieve peak plasma polyphenol concentrations at less than 10 μM [172,174–177].”
- Identification of Amyloid Plaques in Retinas from Alzheimer’s Patients and Noninvasive In Vivo Optical Imaging of Retinal Plaques in a Mouse Model (2010, neutral): “Furthermore, recent studies have reported various approaches to significantly increase curcumin stability and bioavailability in humans (Anand et al., 2007).”